Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 15:45 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
NCT04856176 · Tufts Medical Center · PHASE2 · terminated · last registry update 2026-10-30 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Futility” | – | Registry record, Tufts Medical Center |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CSF2RA within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-10-30Results posted on the registry: Memorial Sloan Kettering Cancer Center, Hu3F8 + GM-CSF (NCT03033303)
- 2026-10-09Also stopped (withdrawn): Georgetown University, NY-ESO-1 Peptide vaccine + Toripalimab-tpzi (NCT05479045)
- 2026-08-05Results posted on the registry: Beth Israel Deaconess Medical Center, GM-CSF + Dendritic Cell/Tumor Fusion Vaccine (NCT00799110)
- 2026-08-05Also stopped (terminated): Beth Israel Deaconess Medical Center, GM-CSF + Dendritic Cell/Tumor Fusion Vaccine (NCT00799110)
- 2026-06-30Results posted on the registry: Academic and Community Cancer Research United, Cyclophosphamide + Multi-epitope Folate Receptor Alpha Peptide Vaccine (NCT03012100)
- 2026-06-29Also stopped (suspended): University of California, Davis, Antineoplastic Vaccine + Sargramostim (NCT05101356)
- 2026-05-05Results posted on the registry: Nationwide Children's Hospital, GM-CSF (NCT03769844)
- 2026-04-23Results posted on the registry: University of Florida, TTRNA-DC vaccines with GM-CSF + Dose-intensified TMZ (NCT03334305)
- 2026-04-23Also stopped (terminated): University of Florida, TTRNA-DC vaccines with GM-CSF + Dose-intensified TMZ (NCT03334305)
- 2026-04-03Results posted on the registry: University of Washington, CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine + Sargramostim (NCT05242965)
- 2026-01-21Results posted on the registry: Children's Oncology Group, Dinutuximab + Eflornithine Hydrochloride (NCT03794349)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision